Il-21 fusion proteins useful as enhancers of anti-cancer immunotherapies

Li Tang, Yugang Guo, Yi Wang
2024
Brevet

Résumé

The present invention relates generally to the field of anti-cancer therapy, in particular to the use of agents or co-agents useful in anti-cancer immunotherapy such as adoptive T-cell transfer (ACT) immunotherapy and immune check-point blockades.

Source officielle

https://infoscience.epfl.ch/record/310042?ln=fr

À propos de ce résultat

Cette page est générée automatiquement et peut contenir des informations qui ne sont pas correctes, complètes, à jour ou pertinentes par rapport à votre recherche. Il en va de même pour toutes les autres pages de ce site. Veillez à vérifier les informations auprès des sources officielles de l'EPFL.

Il-21 fusion proteins useful as enhancers of anti-cancer immunotherapies

Exploration and modulation of mechanical cues for enhanced cancer immunotherapy

Development of cysteine cathepsin inhibitors combined with cell type-specific delivery for the treatment of B-cell lymphoma and solid tumors

Highly effective adoptive t cell therapy

Development of cysteine cathepsin inhibitors combined with cell type-specific delivery for the treatment of B-cell lymphoma and solid tumors

Exploration and modulation of mechanical cues for enhanced cancer immunotherapy

Highly effective adoptive t cell therapy